Currently, there are 46.63M common shares owned by the public and among those 46.33M shares have been available to trade.
The company’s stock has a 5-day price change of 0.55% and -24.59% over the past three months. CLB shares are trading -17.33% year to date (YTD), with the 12-month market performance down to -41.69% lower. It has a 12-month low price of $13.88 and touched a high of $27.94 over the same period. CLB has an average intraday trading volume of 447.96K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -4.75%, -11.83%, and -31.70% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Core Laboratories Inc (NYSE: CLB) shares accounts for 104.02% of the company’s 46.63M shares outstanding.
It has a market capitalization of $682.11M and a beta (3y monthly) value of 2.41. The stock’s trailing 12-month PE ratio is 16.87, while the earnings-per-share (ttm) stands at $0.87. The company has a PEG of 0.83 and a Quick Ratio of 1.73 with the debt-to-equity ratio at 0.92. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.53% over the week and 4.64% over the month.
Analysts forecast that Core Laboratories Inc (CLB) will achieve an EPS of $Albemarle Corporation for the current quarter, $122.59 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Schlumberger N.V. while analysts give the company a high EPS estimate of $Cornerstone Strategic Value Fd. Comparatively, EPS for the current quarter was $Chubb Limited a year ago. Earnings per share for the fiscal year are expected to increase by 16.78%, and 31.26% over the next financial year. EPS should grow at an annualized rate of 20.40% over the next five years, compared to -13.72% over the past 5-year period.
Looking at the support for the CLB, a number of firms have released research notes about the stock. Citigroup stated their Sell rating for the stock in a research note on June 30, 2023, with the firm’s price target at $22-$21.
